ASHTIN BURGESS: Open Payments
NPI 1093550741 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 109 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $1,787
Food & beverage: $1,787
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $304 |
| Janssen Pharmaceuticals, Inc | 15 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $201 |
| ABBVIE INC. | 17 | $169 |
| Vanda Pharmaceuticals Inc. | 8 | $166 |
| Lundbeck LLC | 12 | $151 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| Neurocrine BioSciences, Inc. | 5 | $88 |
| Alkermes, Inc. | 5 | $82 |
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
Products named: Auvelity, REXULTI, CAPLYTA, VRAYLAR, SPRAVATO, FANAPT, INVEGA SUSTENNA, INGREZZA.
Industry payments across AR — which companies pay providers there.
